Skip to main content
  • FOR CONSUMERS
  • CONTACT US
Bayer LogoAleve® Logo
Bayer Logo Aleve® Logo

ATTENTION

The information on this page is intended for healthcare professionals in the United States and is not intended for the general public.

I AM A HEALTHCARE PROFESSIONAL

I AM NOT A HEALTHCARE PROFESSIONAL

Aleve® HCP Homepage
  • EFFICACY AND PAIN GUIDELINES
    Aleve® caplets provide 12-hours of uninterrupted pain relief.
    • Efficacy and Pain Guidelines
      • Dental Pain Studies and Guidelines
      • Primary Dysmenorrhea Study and Guidelines
      • Osteoarthritis Pain Studies and Guidelines
      • Musculoskeletal Pain Studies and Guidelines
      • Additional Clinical Materials
  • Safety
  • FAQ
  • SAMPLES
  • Studies
Bayer Cross Logo
  1. Home
  2. Efficacy and Pain Guidelines
  3. Dental Pain Studies and Guidelines
  4. Non-Opioid Dental Pain Relief
  5. US Opioid Crisis

THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES HAS DECLARED THE NATIONAL OPIOID CRISIS A PUBLIC HEALTH EMERGENCY1

Despite the risk of addiction, similar or lower efficacy and higher rates of acute adverse events compared with OTC NSAIDs, opioids still may be prescribed too often for pain relief. This practice has helped contribute to unprecedented levels of opioid addiction and overdose deaths.2,3

THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES HAS DECLARED THE NATIONAL OPIOID CRISIS A PUBLIC HEALTH EMERGENCY

US map and statistics on Opioid crisis in US.

During the COVID pandemic, the opioid crisis has been exacerbated even further5

The National Center for Health Statistics (NCHS) reported that overdose deaths from opioids rose from 50,178 in 2019 to 105,521 in 2024.5

With the current opioid crisis, consider other options for treating minor dental pain1

A recent study shows that opioids are not associated with greater patient satisfaction for pain management after dental extractions.6

Recommendations from various organizations to use NSAIDs as first line of treatment for pain management.
Dr. M. Ted Wong recommends NSAIDs like Aleve for dental pain to help reduce opioid use.

Aleve® is a non-opioid OTC NSAID that, in a single-center, randomized, double-blind, parallel, placebo-controlled study, was shown to be as effective* as hydrocodone plus acetaminophen (HYD+APAP) for dental pain, lasted longer, and was better tolerated.2

*In hours 0 to 4 of a single-dose dental study of Aleve® (440 mg), HYD+APAP (10 mg + 650 mg), or placebo. Aleve® is indicated for minor aches and pains.2,15

CONSIDER ALEVE® FOR FIRST-LINE TREATMENT OF MINOR DENTAL PAIN2,15

CONSIDER ALEVE® FOR FIRST-LINE TREATMENT OF MINOR DENTAL PAIN2,15

Aleve Yellow Line
Aleve Yellow Line

References 

  1. Department of Health and Human Services. Determination that a public health emergency exists. October 26, 2017. https://www.hhs.gov/sites/default/files/opioid%20PHE%20Declaration-no-sig.pdf 

  2. Cooper SA, Desjardins PJ, Bertoch T, et al. Analgesic efficacy of naproxen sodium versus hydrocodone/acetaminophen in acute postsurgical dental pain: a randomized, double-blind, placebo-controlled trial 2021. doi:10.1080/00325481.2021.2008180. 

  3.  Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician. 2008;11(2 Suppl):S63-S88. 

  4. Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths—United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019;67(51-52):1419-1427.  

  5.  Ahmad FB, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2021. Accessed October 9, 2025. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm 

  6. Nalliah RP, Sloss KR, Kenney BC, et al. Association of opioid use with pain and satisfaction after dental extraction. JAMA Netw Open. 2020;3(3):e200901. doi:10.1001/jamanetworkopen.2020.0901  

  7. American Dental Association announces new policy to combat opioid epidemic. News release. American Dental Association. March 26, 2018. Accessed October 16, 2025. https://www.ada.org/about/press-releases/2018-archives/american-dental-association-announces-new-policy-to-combat-opioid-epidemic  

  8. American Dental Association. Statement on the use of opioids in the treatment of dental pain. October 2016. Accessed October 16, 2025. https://www.ada.org/about/governance/current-policies#substanceusedisorders

  9. American Association of Oral and Maxillofacial Surgeons. Opioid prescribing: acute and postoperative pain management; 2025. White Paper. Accessed October 9, 2025. https://aaoms.org/wp-content/uploads/2024/03/opioid_prescribing.pdf

  10. Nalamachu S, Pendergrass S, Vega C. Over-the-counter analgesics for the management of acute pain:clinical experience in the era of the opioid crisis. Accessed July 28, 2021. https://www.getreliefresponsiblyprofessional.com/sites/getreliefresponsiblyhcp_us/files/over-the-counter-analgesics-for-themanagement-of-acute-pain.pdf 

  11. Dowell D, Haegerich T, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49. doi:10.15585/mmwr.rr6501e1 

  12. Blondell R, Azadfard M, Wisniewski A. Pharmacologic herapy for acute pain. Am Fam Physician. 2013;87(11):766-772. 

  13. Suda K, Zhou J, Rowan S, et al. Overprescribing of opioids to adults by dentists in the U.S., 2011-2015. Am J Prev Med. 2020;58(4):473-486. doi:10.1016/j.amepre.2019.11.006 

  14. Katz J, Smith S, Collins J, et al. Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities. Osteoarthritis Cartilage. 2016;24(3):409-418. doi:10.1016/j.joca.2015.10.006 

  15. Aleve®Caplets. Drug facts. Bayer HealthCare; January 2025 

Aleve® HCP Homepage
  • FOR CONSUMERS
  • CONTACT US
  • PRODUCTS
    • Aleve® Caplets
    • Aleve® Tablets
    • Aleve® Liquid Gels
    • Aleve® Gelcaps
    • Aleve® PM
    • Aleve-D®
  • EFFICACY AND PAIN GUIDELINES
    • Dental Pain Studies and Guidelines
    • Primary Dysmenorrhea Study and Guidelines
    • Osteoarthritis Pain Studies and Guidelines
    • Musculoskeletal Pain Studies and Guidelines
    • Additional Clinical Materials
  • SAFETY
    • FAQ
    • SAMPLES
    • STUDIES

©2026. All rights reserved. Unless otherwise indicated, all trademarks are owned by Bayer and its affiliates, or licensed for its use.

USE AS DIRECTED

  • Bayer Global
  • Bayer US
  • Bayer Consumer Health
  • Conditions of Use
  • Privacy Statement
  • Health Data Privacy Statement
  • Cookie Settings
  • Imprint
  • California Transparency in Supply Chains
  • Money-Back Guarantee
  • AdChoices
  • Do not sell or share my Personal Data
  • Accessibility

Level Access website accessibility icon